Skip to main content

Supportive Care in Cancer

Ausgabe 11/2016

Inhalt (42 Artikel)

Commentary

Is antihistaminergic H2 really useful in prevention of hypersensitivity induced by paclitaxel?

Florian Slimano, Pierre Coliat, Jeanne-Marie Perotin, Juliette Vella-Boucaud, Céline Mongaret, Olivier Bouché

Open Access Commentary

Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East

Dorothy Keefe, Abdullah Al Garni, Antonio Villalon, Azza Hassan, Dora Kwong, Pingping Li, Kazuo Tamura, Jee Hyun Kim, Mastura Md Yusof, Muhammad Zafar Javed, Ravindran Kanesvaran, Ruey-Kuen Hsieh, Matti Aapro

Letter to the editor

Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): a case report

Kae Okuma, Kenshiro Shiraishi, Yoshiaki Kanai, Keiichi Nakagawa

Original Article

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis

Massimo Breccia, Guendalina Graffigna, Sara Galimberti, Alessandra Iurlo, Ester Pungolino, Michele Pizzuti, Alessandro Maggi, Franca Falzetti, Silvana Franca Capalbo, Tamara Intermesoli, Margherita Maffioli, Chiara Elena, Alessandro Melosi, Federico Simonetti, Enrico Capochiani, Roberta Della Seta, Matteo Pacilli, Mario Luppi, Nicola Di Renzo, Lucia Mastrullo, Elena Trabacchi, Daniele Vallisa, Davide Rapezzi, Ester Maria Orlandi, Carlo Gambacorti-Passerini, Fabio Efficace, Giuliana Alimena

Original Article

Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer—chemotherapy toxicity and prognostic value

Drazena Srdic, Sanja Plestina, Ana Sverko-Peternac, Nora Nikolac, Ana-Maria Simundic, Miroslav Samarzija

Open Access Original Article

Predicting trajectories of behavioral adjustment in children diagnosed with acute lymphoblastic leukemia

Simone M. Sint Nicolaas, Peter M. Hoogerbrugge, Esther M. M. van den Bergh, José A. E. Custers, Sofia Gameiro, Reinoud J. B. J. Gemke, Chris M. Verhaak

Original Article

Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants

Hiromichi Maeda, Maho Sato, Michiya Kobayashi, Nobuhiro Takiguchi, Takaki Yoshikawa, Shigefumi Yoshino, Kazuhiro Yoshida, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita

Original Article

Prevalence and risk factors associated with pain 21 months following surgery for breast cancer

Niamh Moloney, Jennie Man Wai Sung, Sharon Kilbreath, Elizabeth Dylke

Original Article

Understanding the full breadth of cancer-related patient costs in Ontario: a qualitative exploration

Christopher J. Longo, Margaret Fitch, Michel Grignon, Alison McAndrew

Original Article

Which items on the distress thermometer problem list are the most distressing?

Kerrie Ann Clover, Christopher Oldmeadow, Louise Nelson, Kerry Rogers, Alex J Mitchell, Gregory Carter

Original Article

Gaps exist between patients’ experience and clinicians’ awareness of symptoms after chemotherapy: CINV and accompanying symptoms

Sun Young Rha, Su Kyung Song, Chung Eun Lee, Yeonhee Park, Jiyeon Lee

Open Access Original Article

Qualitative assessment of information and decision support needs for managing menopausal symptoms after breast cancer

Lynda G. Balneaves, Dimitra Panagiotoglou, Alison S. A. Brazier, Leah K. Lambert, Antony Porcino, Margaret Forbes, Cheri Van Patten, Tracy L. O. Truant, Dugald Seely, Dawn Stacey

Original Article

Outcome prognostic factors in inoperable malignant bowel obstruction

Margarita Romeo, Maria de los LLanos Gil, José Luís Cuadra Urteaga, Laia Vilà, Sara Ahlal, Alberto Indacochea, Núria Pardo, Joaquim Radua, Albert Font, Albert Tuca

Original Article

Social competence in children and young people treated for a brain tumour

Alice Emond, Lesley Edwards, Samantha Peacock, Catherine Norman, Michael Evangeli

Original Article

Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer

Heather J. Leach, Jessica M. Danyluk, Kathryn C. Nishimura, S. Nicole Culos-Reed

Original Article

Post-intensive care unit syndrome in gynecologic oncology patients

Camille C. Gunderson, Adam C. Walter, Rachel Ruskin, Kai Ding, Kathleen N. Moore

Open Access Original Article

The need for supportive care among head and neck cancer patients: psychometric assessment of the Dutch version of the Supportive Care Needs Survey Short-Form (SCNS-SF34) and the newly developed head and neck cancer module (SCNS-HNC)

Femke Jansen, Birgit I. Witte, Cornelia F. van Uden-Kraan, Anna M. Braspenning, C. René Leemans, Irma M. Verdonck-de Leeuw

Original Article

Predisposing factors for postoperative nausea and vomiting in gynecologic tumor patients

Daiane Spitz de Souza, Amine Farias Costa, Gabriela Villaça Chaves

Original Article

Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners

Nancy K. Janz, Yun Li, Lauren J. Beesley, Lauren P. Wallner, Ann S. Hamilton, Rebecca A. Morrison, Sarah T. Hawley

Original Article

The perceptions of Australian oncologists about cognitive changes in cancer survivors

Kate Smidt, Lynette Mackenzie, Haryana Dhillon, Janette Vardy, Joanne Lewis, Siew Yim Loh

Original Article

Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines

Ting-Yao Wang, Wei-Ming Chen, Lan-Yan Yang, Chao-Yu Chen, Wen-Chi Chou, Yi-Yang Chen, Chih-Cheng Chen, Kuan-Der Lee, Chang-Hsien Lu

Original Article

Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT

Eun Young Kim, Young Saing Kim, Inkeun Park, Hee Kyung Ahn, Eun Kyung Cho, Yu Mi Jeong, Jeong Ho Kim

Original Article

“Perhaps I will die young.” Fears and worries regarding disease and death among Danish adolescents and young adults with cancer. A mixed method study

Bibi Hølge-Hazelton, Helle U. Timm, Christian Graugaard, Kirsten A. Boisen, Cecilie Dyg Sperling

Original Article

Symptoms and quality of life in patients with brain metastases receiving whole-brain radiation therapy

Erin Wong, Liying Zhang, Leigha Rowbottom, Nicholas Chiu, Leonard Chiu, Rachel McDonald, May Tsao, Elizabeth Barnes, Cyril Danjoux, Edward Chow

Original Article

Prevalence of unmet needs and correlated factors in advanced-stage cancer patients receiving rehabilitation

Takaaki Hasegawa, Naoya Goto, Naoto Matsumoto, Yusuke Sasaki, Takashi Ishiguro, Nanori Kuzuya, Yasuyuki Sugiyama

Original Article

Caregivers’ perspectives on oral health problems of end-of-life cancer patients

Miriam O. Ezenwa, Dena J. Fischer, Joel Epstein, Julie Johnson, Yingwei Yao, Diana J. Wilkie

Open Access Original Article

Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment

Noah R. Zanville, Kelly N. H. Nudelman, Dori J. Smith, Diane Von Ah, Brenna C. McDonald, Victoria L. Champion, Andrew J. Saykin

Original Article

Rehabilitation pathways in adult brain tumor patients in the first 12 months of disease. A retrospective analysis of services utilization in 719 patients

Andrea Pace, Veronica Villani, Cristiano Parisi, Stefano Di Felice, Margaux Lamaro, Chiara Falcicchio, Alessandro Bonucci, Patrizia Pugliese, Anteo di Napoli, Domenico Di Lallo

Original Article

Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer

Sushma Jonna, Leslie Chiang, Jingxia Liu, Maria B. Carroll, Kellie Flood, Tanya M. Wildes

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.